4//SEC Filing
Gall Matthew 4
Accession 0001209191-22-018668
CIK 0001808865other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 8:00 PM ET
Size
9.2 KB
Accession
0001209191-22-018668
Insider Transaction Report
Form 4
Gall Matthew
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-11+85,000→ 85,000 totalExercise: $36.21Exp: 2032-03-11→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest over 4 years, with 25% vesting on March 11, 2023 and thereafter in equal monthly installments over the next 36 months, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001816194
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 8:00 PM ET
- Size
- 9.2 KB